annual retained earnings:
-$3.96B-$569.18M(-16.80%)Summary
- As of today (July 7, 2025), RARE annual retained earnings is -$3.96 billion, with the most recent change of -$569.18 million (-16.80%) on December 31, 2024.
- During the last 3 years, RARE annual retained earnings has fallen by -$1.88 billion (-90.82%).
- RARE annual retained earnings is now -48420.47% below its all-time high of -$8.15 million, reached on December 31, 2011.
Performance
RARE Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
-$4.11B-$151.08M(-3.82%)Summary
- As of today (July 7, 2025), RARE quarterly retained earnings is -$4.11 billion, with the most recent change of -$151.08 million (-3.82%) on March 31, 2025.
- Over the past year, RARE quarterly retained earnings has dropped by -$549.58 million (-15.44%).
- RARE quarterly retained earnings is now -15081.92% below its all-time high of -$27.06 million, reached on December 31, 2012.
Performance
RARE quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
RARE Retained earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.8% | -15.4% |
| 3 y3 years | -90.8% | -84.5% |
| 5 y5 years | -176.1% | -164.7% |
RARE Retained earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -90.8% | at low | -72.3% | at low |
| 5 y | 5-year | -176.1% | at low | -169.1% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
RARE Retained earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | -$4.11B(+3.8%) |
| Dec 2024 | -$3.96B(+16.8%) | -$3.96B(+3.5%) |
| Sep 2024 | - | -$3.82B(+3.6%) |
| Jun 2024 | - | -$3.69B(+3.7%) |
| Mar 2024 | - | -$3.56B(+5.0%) |
| Dec 2023 | -$3.39B(+21.8%) | -$3.39B(+3.8%) |
| Sep 2023 | - | -$3.26B(+5.1%) |
| Jun 2023 | - | -$3.10B(+5.4%) |
| Mar 2023 | - | -$2.94B(+5.9%) |
| Dec 2022 | -$2.78B(+34.1%) | -$2.78B(+5.8%) |
| Sep 2022 | - | -$2.63B(+10.3%) |
| Jun 2022 | - | -$2.38B(+7.1%) |
| Mar 2022 | - | -$2.23B(+7.3%) |
| Dec 2021 | -$2.07B(+28.0%) | -$2.07B(+6.3%) |
| Sep 2021 | - | -$1.95B(+3.9%) |
| Jun 2021 | - | -$1.88B(+7.0%) |
| Mar 2021 | - | -$1.76B(+8.4%) |
| Dec 2020 | -$1.62B(+13.0%) | -$1.62B(+1.5%) |
| Sep 2020 | - | -$1.60B(+4.5%) |
| Jun 2020 | - | -$1.53B(-1.6%) |
| Mar 2020 | - | -$1.55B(+8.3%) |
| Dec 2019 | -$1.43B | -$1.43B(+7.0%) |
| Sep 2019 | - | -$1.34B(+9.2%) |
| Jun 2019 | - | -$1.23B(+8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -$1.13B(+9.4%) |
| Dec 2018 | -$1.03B(+23.7%) | -$1.03B(+9.3%) |
| Sep 2018 | - | -$942.46M(+10.2%) |
| Jun 2018 | - | -$855.15M(+6.6%) |
| Mar 2018 | - | -$802.42M(-3.6%) |
| Dec 2017 | -$832.67M(+57.0%) | -$832.67M(+10.9%) |
| Sep 2017 | - | -$750.94M(+11.8%) |
| Jun 2017 | - | -$671.71M(+12.2%) |
| Mar 2017 | - | -$598.82M(+12.9%) |
| Dec 2016 | -$530.53M(+86.4%) | -$530.53M(+15.5%) |
| Sep 2016 | - | -$459.25M(+16.5%) |
| Jun 2016 | - | -$394.34M(+16.9%) |
| Mar 2016 | - | -$337.42M(+18.5%) |
| Dec 2015 | -$284.66M(+104.7%) | -$284.66M(+24.1%) |
| Sep 2015 | - | -$229.44M(+20.6%) |
| Jun 2015 | - | -$190.21M(+18.6%) |
| Mar 2015 | - | -$160.42M(+15.4%) |
| Dec 2014 | -$139.04M(+85.8%) | -$139.04M(+13.7%) |
| Sep 2014 | - | -$122.30M(+14.9%) |
| Jun 2014 | - | -$106.45M(+14.6%) |
| Mar 2014 | - | -$92.87M(+24.1%) |
| Dec 2013 | -$74.84M(+176.6%) | -$74.84M(+31.6%) |
| Sep 2013 | - | -$56.85M(+110.1%) |
| Dec 2012 | -$27.06M(+231.8%) | -$27.06M |
| Dec 2011 | -$8.15M | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual retained earnings?
- What is the all time high annual retained earnings for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual retained earnings year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly retained earnings?
- What is the all time high quarterly retained earnings for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly retained earnings year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual retained earnings?
The current annual retained earnings of RARE is -$3.96B
What is the all time high annual retained earnings for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual retained earnings is -$8.15M
What is Ultragenyx Pharmaceutical Inc. annual retained earnings year-on-year change?
Over the past year, RARE annual retained earnings has changed by -$569.18M (-16.80%)
What is Ultragenyx Pharmaceutical Inc. quarterly retained earnings?
The current quarterly retained earnings of RARE is -$4.11B
What is the all time high quarterly retained earnings for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly retained earnings is -$27.06M
What is Ultragenyx Pharmaceutical Inc. quarterly retained earnings year-on-year change?
Over the past year, RARE quarterly retained earnings has changed by -$549.58M (-15.44%)